MOPP after two decades
SA Rosenberg
JCO Sep 1 1986: 1289–1290. [PDF]
Staging and the evaluation of prognosis for patients with small-cell carcinoma of the lung
DE Bergsagel and R Feld
JCO Sep 1 1986: 1291–1292. [PDF]
Oncogenes and tumor progression
RA Weinberg
JCO Sep 1 1986: 1293–1294. [PDF]
	Twenty years of MOPP therapy for Hodgkin's disease
	DL Longo, RC Young, M Wesley, SM Hubbard, PL Duffey, ES Jaffe, and VT DeVita, Jr
	JCO Sep 1 1986: 1295–1306. [Abstract] [PDF]
	Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants
	K Osterlind, HH Hansen, M Hansen, P Dombernowsky, and PK Andersen
	JCO Sep 1 1986: 1307–1313. [Abstract] [PDF]
	Treatment of small-cell lung cancer on protocol: potential bias of results
	E Quoix, H Finkelstein, N Wolkove, and H Kreisman
	JCO Sep 1 1986: 1314–1320. [Abstract] [PDF]
	Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients
	J Lundy, R Grimson, Y Mishriki, S Chao, S Oravez, F Fromowitz, and MV Viola
	JCO Sep 1 1986: 1321–1325. [Abstract] [PDF]
	A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer
	RB Buchanan, RW Blamey, KR Durrant, A Howell, AG Paterson, PE Preece, DC Smith, CJ Williams, and RG Wilson
	JCO Sep 1 1986: 1326–1330. [Abstract] [PDF]
	Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB Study
	MR Cooper, OR McIntyre, KJ Propert, S Kochwa, K Anderson, M Coleman, RA Kyle, D Prager, S Rafla, and B Zimmer
	JCO Sep 1 1986: 1331–1339. [Abstract] [PDF]
	Importance of primary site in assessing chemotherapy response and 7- year survival data in advanced squamous-cell carcinomas of the head and neck treated with initial combination chemotherapy without cisplatin
	BT Hill, LA Price, and K MacRae
	JCO Sep 1 1986: 1340–1347. [Abstract] [PDF]
	Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies
	JA Levi, RM Fox, MH Tattersall, RL Woods, D Thomson, and G Gill
	JCO Sep 1 1986: 1348–1355. [Abstract] [PDF]
	Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer
	YZ Patt, AW Boddie, Jr, C Charnsangavej, JA Ajani, S Wallace, M Soski, L Claghorn, and GM Mavligit
	JCO Sep 1 1986: 1356–1364. [Abstract] [PDF]
	A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate
	EJ Seifter, PA Bunn, MH Cohen, RW Makuch, NR Dunnick, N Javadpour, H Bensimon, JL Eddy, JD Minna, and DC Ihde
	JCO Sep 1 1986: 1365–1373. [Abstract] [PDF]
	Chemotherapy of drug-resistant ovarian cancer: a Southwest Oncology Group Study
	LR Laufman, JB Green, DS Alberts, R O'Toole, RD Hilgers, DC Young, F Lin, and SE Rivkin
	JCO Sep 1 1986: 1374–1379. [Abstract] [PDF]
	Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease
	MB Atkins, JA Gould, M Allegretta, JJ Li, RA Dempsey, RA Rudders, DR Parkinson, S Reichlin, and JW Mier
	JCO Sep 1 1986: 1380–1391. [Abstract] [PDF]
	Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin
	PA Reece, I Stafford, J Russell, and PG Gill
	JCO Sep 1 1986: 1392–1398. [Abstract] [PDF]
	Mitomycin C skin toxicity studies in mice: reduced ulceration and altered pharmacokinetics with topical dimethyl sulfoxide
	RT Dorr, MJ Soble, JD Liddil, and JH Keller
	JCO Sep 1 1986: 1399–1404. [Abstract] [PDF]
	Vascular toxicity associated with antineoplastic agents
	DC Doll, QS Ringenberg, and JW Yarbro
	JCO Sep 1 1986: 1405–1417. [Abstract] [PDF]
Initial chemotherapy doses for elderly patients with malignant lymphoma
MJ O'Connell, JD Earle, DP Harrington, GJ Johnson, and JH Glick
JCO Sep 1 1986: 1418a. [PDF]
Evaluating new drugs: a three-step approach
ZA Arlin
JCO Sep 1 1986: 1418b–1419. [PDF]
The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease
KJ Propert, JR Anderson, M Barcos, and AJ Gottlieb
JCO Sep 1 1986: 1419–1420. [PDF]
Chemotherapy of diffuse large-cell lymphoma--rapidly responding patients have more durable remissions
JR Anderson, S Ginsberg, and AJ Gottlieb
JCO Sep 1 1986: 1420–1421. [PDF]
The usefulness of analysis of survival by tumor response
P Selby and T McElwain
JCO Sep 1 1986: 1421–1422. [PDF]
ASCO--as a young adult
JR Durant
JCO Sep 1 1986: 1431–1435. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.